Representing pharmaceutical, medical device and life sciences litigation today requires seasoned, innovative and scientifically focused defense counsel, which accurately describes Maynard Nexsen’s team. Our attorneys boast extensive experience representing pharmaceutical, medical device, and life sciences companies as national counsel, MDL liaison counsel, and regional and local counsel.

Maynard Nexsen handles all aspects of this litigation, particularly mass torts: proactive, in-depth fact investigations, strategic client coordination and reporting systems, major e-discovery projects, voluminous medical records analysis, large-scale discovery and motion practice, multiple trials, and key appeals.

Maynard Nexsen has defended a myriad of medical products including pharmaceuticals (prescription, over-the-counter drugs and most recently opioids), biologics, pelvic mesh, fracture fixation devices, contraceptive devices, breast implants, anti-reflux devices, dialyzers, latex gloves, incubators, component parts of oxygen delivery systems, and laser treatment devices.

We have extensive experience as discovery counsel in MDL litigation interviewing and defending sales representatives and deposing hundreds of treating physicians. We have also successfully collaborated with and defended company witnesses through discovery and trial, as well as handling expert witnesses from recruitment through trial.

We coordinate seamlessly with other firms as part of virtual defense teams, and we maintain excellent working relationships with national counsel. The Firm also embraces project management to streamline defense protocols and control costs.

Seasoned patent litigators with extensive trial experience in pharmaceutical and biotechnology cases are at the center of Maynard Nexsen’s intellectual property practice. Our lawyers have a successful track record in many patent actions involving Abbreviated New Drug Applications (ANDA) under the Hatch-Waxman Act directed to dozens of different small and large molecules.

Lawyers on our patent litigation team have represented both generic and branded pharmaceutical companies in cases involving some of their most important drugs.

The firm’s patent litigators appear regularly before the federal district courts in Hatch-Waxman matters and have successfully argued appeals to the U.S. Court of Appeals for the Federal Circuit. Many of the lawyers on our team are registered to practice in the United States Patent and Trademark Office and represent clients in Patent Office proceedings and trials, including inter partes review (IPR) and post-grant invalidity challenges under the America Invents Act.

Maynard Nexsen lawyers also advise pharmaceutical and biotechnology clients in a wide range of areas, including biologics, biosimilars, pharmaceuticals, medical devices, diagnostic technologies and drug delivery systems. Our team includes attorneys with advanced scientific degrees who stand by our clients at the intersection of complex scientific and clinical issues and the law, enabling our litigators to simplify the presentation of complex arguments and provide clients with winning results in the courts and other tribunals. Our attorneys know the science and the technology, focus on the business concerns of our clients, and collaborate with our clients to develop effective litigation strategies tailored to each matter that often lead to favorable settlements before trial.

We are client-driven with decades of experience advising both large and small pharmaceutical and biotech companies in all aspects of their businesses, and we are committed to providing excellent service at an uncommon value so that our clients can meet their business objectives in an efficient and cost-effective way.

Jump to Page